Ex-Adviser Cops To Insider Trading Tied To $11B Pharma Deal

Law360, New York (September 30, 2013, 6:14 PM ET) -- A former Florida financial adviser on Monday copped to insider trading charges tied to Gilead Sciences Inc.'s $11 billion acquisition of a New Jersey-based biotechnology company, admitting to a scheme that netted a trio of conspirators more than $700,000 from the pharmaceutical giant's deal.  

Kevin Dowd, 38, of Boca Raton, pled guilty to conspiracy to commit securities fraud in connection to insider information he shared with two co-conspirators, according to court documents. Dowd admitted to providing two people with information regarding Gilead's plans to purchase Pharmasset...
To view the full article, register now.